Skip to content

Clinical trials

Phase 2 Gliosarcoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Phase: Phase 2 Country / region: Canada Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20071
20091
20121
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Radiation Therapy Oncology Group2
Arno Therapeutics1
DNAtrix, Inc.1
NCIC Clinical Trials Group1
Ottawa Regional Cancer Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma9
Gliosarcoma9
Brain Neoplasms6
Central Nervous System Neoplasms5
Astrocytoma3
Glioma3
Oligodendroglioma3
Adenocarcinoma, Follicular1
Adrenocortical Carcinoma1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.